TCR-T Therapy: 49% Risk Cut & 39% Response Melanoma Skin Cancer Treatment 2 Mins Read Introduction to a Revolutionary Cancer Approach This treatment starts with T cells from the patient. Doctors add receptors to spot…
Uveal Melanoma: Tebentafusp three-year overall survival data Phase 3 KIMMTRAK trial Melanoma Skin Cancer Treatment 2 Mins Read By. Mohammed Dar, MDDate. November 02, 2023Mohammed Dar, MD, observed significant advancements in the treatment of metastatic uveal melanoma, particularly…
